drugset / Trial / NCT00344981
Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression
RandomizedParallel-groupOpen-labelTreatment
Summary
Study Hypothesis Evaluation of the durability of the combination Tenofovir and Hydroxyurea to maintain viral suppression below 50 copies/ml in volunteers who have achieved viral suppression on a standard HAART regimen.
Timeline
- Start
- 2003-06
- Primary completion
- 2006-11
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxyurea | Other / unclassified | 500 mg | — |
| Subject | Tenofovir | Small molecule | 300 mg | — |